“Nobiletin acts as a potential anticancer agent against osteosarcoma by regulating ERK and AKT signaling pathways” (2014) Bangladesh Journal of Pharmacology, 9(3), pp. 406–412. doi:10.3329/bjp.v9i3.19567.